KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.

BMJ 383 p2665

PMID37973164
PMCIDPMC10652813
DOI10.1136/bmj.p2665
发表日期2023-11-16
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。